Ginkgo ketone ester tablets for the treatment of cognitive impairment associated with chemotherapy for breast cancer - a prospective cohort study
BackgroundChemotherapy-related cognitive impairment (CRCI) affects up to 75% of breast cancer patients during treatment, with 35% experiencing persistent post-treatment deficits. Current interventions show limited efficacy, creating urgent need for targeted therapies. Ginkgo Ketone Ester (GBE), cont...
Saved in:
| Main Authors: | Jiajing Chen, Lixin Chen, Kexin Jiang, Dandan Wang, Chunyu Wu, Yuenong Qin, Sheng Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1615505/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PREPARATION TECHNOLOGY OF TABLETS WITH COMBINATIONS OF THE EXTRACT OF GINKGO AND VINPOCETIN
by: N. V. Slovesnova, et al.
Published: (2019-01-01) -
Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment
by: YoungSoon Yang, et al.
Published: (2025-08-01) -
Ginkgo Biloba extract: review and assessment of health benefits and potential side effects
by: Julia Mierzwińska-Mucha, et al.
Published: (2025-05-01) -
Safety and efficacy of feed additives consisting of ginkgo tinctures obtained from the leaves of Ginkgo biloba L. for use in all animal species (FEFANA asbl)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2024-05-01) -
Microscopical diagnostic elements of leaves of Ginkgo biloba L. and herbs of a Filipendula ulmaria (L.) Maxim . in the tablets «GINKGOTROPIL»
by: J. V. Daironas, et al.
Published: (2016-03-01)